In this study, we investigated the mechanisms underlying nicotine's effects on HCC progression through α7nAChR and JAK2 signaling and the reversal of those effects by DHCT, a novel kinase inhibitor. This evidence concerns the gene JAK2 and hepatocellular carcinoma.